Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A

Andelyn Biosciences, Inc. United Kingdom United States of America Ohio

View original content:https://www.prnewswire.co.uk/news-releases/andelyn-biosciences-and-armatus-bio-partner-to-manufacture-suspension-based-aav-gene-therapy-for-rare-neurological-disease-charcot-marie-tooth-type-1a-cmt1a-302034771.html